Literature DB >> 4135609

Risk of transfusing blood containing antibody to hepatitis-B surface antigen.

R D Aach, H J Alter, F B Hollinger, P V Holland, J J Lander, J L Melnick, J M Weiler.   

Abstract

Mesh：

Substances：

Year:  1974        PMID： 4135609     DOI： 10.1016/s0140-6736(74)91485-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Development and use of a micro haemagglutination inhibition (HAI) technique, based on Hepatest, for the detection and quantitation of hepatitis B surface antibody (Anti-HBs) in blood donors.

Authors:  I C Wiseman
Journal:  J Clin Pathol       Date:  1977-01       Impact factor: 3.411

Review 2.  Serology and epidemiology.

Authors:  J H Walsh
Journal:  West J Med       Date:  1975-09

3.  Transfusion-associated hepatitis before the screening of blood for hepatitis risk factors.

Authors:  Ronald E Engle; Jens Bukh; Harvey J Alter; Suzanne U Emerson; Joni L Trenbeath; Hanh T Nguyen; Alicia Brockington; Tanaji Mitra; Robert H Purcell
Journal:  Transfusion       Date:  2014-05-05       Impact factor: 3.157

4.  Occurrence of hepatitis and hepatitis B surface antigen in adult patients with acute leukemia.

Authors:  D H Cowan; G M Kouroupis; W D Leers
Journal:  Can Med Assoc J       Date:  1975-03-22       Impact factor: 8.262

5.  Reducing the risk of hepatitis B virus transfusion-transmitted infection.

Authors:  Christoph Niederhauser
Journal:  J Blood Med       Date:  2011-07-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.